首页> 外文期刊>The Journal of biological chemistry >Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.
【24h】

Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.

机译:ELL复合物EAP30亚基的克隆和表征,该亚基赋予RNA聚合酶II对转录的去抑制。

获取原文
获取原文并翻译 | 示例

摘要

The product of the human oncogene ELL encodes an RNA polymerase II transcription factor that undergoes frequent translocation in acute myeloid leukemia (AML). In addition to its elongation activity, ELL contains a novel type of RNA polymerase II interaction domain that is capable of repressing polymerase activity in promoter-specific transcription. Remarkably, the ELL translocation that is found in patients with AML results in the deletion of exactly this functional domain. Here we report that the EAP30 subunit of the ELL complex has sequence homology to the Saccharomyces cerevisiae SNF8, whose genetic analysis suggests its involvement in the derepression of gene expression. Remarkably, EAP30 can interact with ELL and derepress ELL's inhibitory activity in vitro. This finding may reveal a key role for EAP30 in the pathogenesis of human leukemia.
机译:人类癌基因 ELL 的产物编码一种 RNA 聚合酶 II 转录因子,该转录因子在急性髓系白血病 (AML) 中频繁易位。除了其延伸活性外,ELL还含有一种新型的RNA聚合酶II相互作用结构域,能够抑制启动子特异性转录中的聚合酶活性。值得注意的是,在 AML 患者中发现的 ELL 易位导致该功能域的缺失。在这里,我们报告了ELL复合物的EAP30亚基与酿酒酵母SNF8具有序列同源性,其遗传分析表明它参与了基因表达的去抑制。值得注意的是,EAP30可以与ELL相互作用,并在体外解压ELL的抑制活性。这一发现可能揭示了EAP30在人类白血病发病机制中的关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号